Breakpoint Survey - Digital Platforms |
CLSI M100 is a critical resource for antimicrobial susceptibility testing (AST) and clinical decision‑making. This survey is intended to better understand how laboratories access and use CLSI breakpoints, how breakpoint changes are interpreted and implemented, and where challenges may arise. We appreciate your time and feedback.